People Moves: Kadestone Capital Corp. announces the appointment of Dr. Anthony Holler as Chairman
Press Release - Kadestone Capital Corp. ("Kadestone") (TSX-V: KDSX), a leading vertically integrated property company, announced on Monday that its Board of Directors had appointed Dr. Anthony Holler as Board Chair following the company's annual general meeting (AGM) of shareholders which was held on June 24, 2022, in Vancouver, British Columbia.
Dr. Holler was CEO of ID Biomedical from 1999 until 2005 when the company was sold to GlaxoSmithKline for $1.7 billion.
He currently serves as the Chairman of the Board of Perimeter Medical Imaging AI Inc. and CEO and Chairman of the
Board for Sunniva Inc. Previously, Dr. Holler was Chairman of the Board of Directors of CRH Medical from December
2005 to March 2020. Dr. Holler was also Chairman of Corriente Resources Inc., which sold for approximately $700 million
to CRCC-Tongguan Investment Co. in 2010. Before his involvement in public markets, Dr. Holler served as an Emergency
Physician at University Hospital at the University of British Columbia. He holds a Bachelor of Science Degree and a Medical
Degree from the University of British Columbia.
At the AGM, the Shareholders elected to the Board, by ordinary resolution, Brent Billey, David Negrin, Norm Mayr,
Jacqueline Tucker and Dr. Anthony Holler, to serve in office until the next AGM or until their
successors are duly elected or appointed.
In addition, at the AGM, the Shareholders approved: (i) the re-appointment of Davidson & Company LLP as auditors
of the Company; and (ii) the Company's amended and restated stock option plan.